PZ Cormay, listed supplier and distributor of diagnostic reagents and equipment, signalled that it might upgrade its profit forecast for 2010 in the fourth quarter, amid strong sales growth. CEO Tomasz Tuora revealed that the company was realising its sales targets even despite the fact that the launch of a new haematology analyser had to be postponed. It is now expected to take place in Q4, which should boost revenues further. In 2011 Cormay plans to sell 150 such devices, which is to help the company achieve 30% organic growth in sales, up from PLN 60m (€15.2m) projected for this year.
At the same time, Mr. Tuora reiterated that takeover talks with an unnamed US maker of protein-specific reagents were at a very advanced stage and should be completed before the end of the year. Coupled with organic growth, this should help the company achieve a 70% rise in revenues next year. PZ Cormay would fund the deal from a new share issue of up to PLN 24m (€6.1m), he indicated.
1 year subscription to internet service providing market news, analyses and analytical articles
Pharma Poland Online provides news, articles and market data on the pharmaceutical market in Poland, from manufacturers and distributors to medical devices and research developments. We have been covering this sector in detail since 2004 and an archive is available. Approximately 120 industry updates are added each month. For timely news delivery, custom newsletters can be sent directly to your e-mail account, with content personalisation.
Subscription 1 year
Language: English
Delivery: online access
1 year subscription: (52 issues of weekly news and 12 issues of monthly analysis)
Pharma Poland News is an English language information service covering the pharmaceutical sector in Poland, and broadening its horizons to other Central and Eastern European countries. The service includes weekly and monthly newsletters, both delivered by email in pdf format.
Date: Periodic publication
Language: English
Delivery: PDF file
12-month subscription (26 issues of biweekly news)
Central Europe Pharma News is a bi-weekly newsletter delivered in PDF format directly to your inbox. Each edition of the newsletter delivers news and analysis of the pharmaceutical sector in Bulgaria, Czech Republic, Hungary, Romania, Poland and Slovakia, including an in-depth feature on the pharmaceutical industry in the Central & Eastern Europe region written by PMR market analysts. A list of upcoming events relevant to the region and a company index are included in every issue.
Date: Periodic publication
Language: English
No. pages: n/a
Delivery: PDF file
PMRis a British-American company providing market information, advice and services to international businesses interested in Central and Eastern Europe as well as other emerging markets. PMR key areas of operation include business publications (through PMR Publications), consultancy (through PMR Consulting) and market research (through PMR Research). Being present on the market since 1995, employing highly skilled staff, offering high international standards in projects and publications, providing one of most frequently visited and top-ranked websites, PMR is one of the largest companies of its type in the region.